Furthermore you will take into account GxE, though this is complex because we rarely know these terms - this looks like variable penetrance to us.
Furthermore you will take into account GxE, though this is complex because we rarely know these terms - this looks like variable penetrance to us.
Interestingly in our own work on common variants to OCT based retinal phenotypes we could see some evidence of 2 loci GxG and also association with a rare gene locus with variable penetrance journals.plos.org/plosgenetics...
Another aspect is that we often use additive parameters, eg, the slope of the association, often called beta, in meta-analysis or other analyses, such as Mendelian Randomisation. The assumption is that this slope (beta) is well estimated and slope by GWAS
However, in the scenario of overdominance (the hetrezygote mean is above or below one of the homozygote means) - impossible to get for additive models - the additive beta estimate becomes an unstable, frequency dependent parameter. This is ... not healthy for on-going analysis.
Finally of course discovering GxE effects gives us new insights into environmental impacts - and sometimes those environmental impacts are easier to change than the genetic basis of course (eg, stopping smoking, or stopping drinking)
Similarly discovering 2-loci GxG effects - which are as rare as hen's teeth in human GWAS (though see above on our OCT study) shows us new biology; like all genetics, low variance of genetic variants does not imply low impact if drugged (cf statins and HMG-CoA Reductase)
The medaka paper was a tour de force lead by two great students: @saulpierotti.bsky.social in my research group and Bettina Welz in @wittbrodtlab.bsky.social's group.